ARCHIVES

OMB Restrictions On Reprogramming Could Result In Inefficient Last Minute Spending By Institutes

This article is from The Cancer Letter archive.

Vol. 11 No. 35 | September 13, 1985

Download PDF Visit The Full Archive

Related Articles

NCI Told To “Cut Out The Nonsense,” Adequately Fund Programs At Centers Required By Mandates

November 5, 1976

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

Duke wins Avon-NCI funding.

October 31, 2003

Device Maker Threatens Legal Action Against Doctor Who Launched Campaign to End Power Morcellation

September 5, 2014

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004